Musashi2 sustains the mixed-lineage leukemia–driven stem cell regulatory program-Reference-Cited by-同舟云学术

Musashi2 sustains the mixed-lineage leukemia–driven stem cell regulatory program

Published:2015-02-09 Issue:3 Volume:125 Page:1286-1298
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Park Sun-Mi,Gönen Mithat,Vu Ly,Minuesa Gerard,Tivnan Patrick,Barlowe Trevor S.,Taggart James,Lu Yuheng,Deering Raquel P.,Hacohen Nir,Figueroa Maria E.,Paietta Elisabeth,Fernandez Hugo F.,Tallman Martin S.,Melnick Ari,Levine Ross,Leslie Christina,Lengner Christopher J.,Kharas Michael G.

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference76 articles.

1. Epigenetic Reprogramming in Cancer

2. Recurring Mutations Found by Sequencing an Acute Myeloid Leukemia Genome

3. Secondary Leukemia Associated with the Anti-Cancer Agent, Etoposide, a Topoisomerase II Inhibitor

4. MLL translocations, histone modifications and leukaemia stem-cell development

5. New insights to the MLL recombinome of acute leukemias

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer stem cells: advances in knowledge and implications for cancer therapy;Signal Transduction and Targeted Therapy;2024-07-05

2. Post-transcriptional regulation by the CCR4-NOT deadenylase complex maintains redox homeostasis in insulin biosynthesis in mouse pancreatic β cells;2024-06-29

3. Dysregulated innate immune signaling cooperates with RUNX1 mutations to transform an MDS-like disease to AML;iScience;2024-06

4. Jolkinolide B inhibits the progression of hepatocellular carcinoma by regulating Musashi-2 protein;PLOS ONE;2024-04-17

5. Loss of RNA-binding protein CELF2 promotes acute leukemia development via FAT10-mTORC1;Oncogene;2024-03-21